Most ofthe CD5+ DLBCL subtypes showed centroblastic morphology and had immunophenotypiccharacteristics of CD5+, CD10−, CD19+, CD20+, CD23−, and cyclin D1−. This evidence concerns the gene CD5 and diffuse large B-cell lymphoma.